Share this link via:
The Single-Use Assemblies Market size was valued at around 12.66 Billion in 2023 and is expected to reach a value of USD 61.04 Billion by 2032, at a CAGR of 19.1% over the forecast period (2024–2032) according to a new report by Intellectual Market Insights Research.
Single-use, (SU) assemblies are defined by Aorn as the following; pre-assembled plastic fluid path, Self-contained product. They consist of a number of standard parts which are combined jointly, and usually the final product is ready for use and often it is gamma-irradiated to make it sterile. Popular products used in industries are sampling bottles, filter, tubing, check valves, clamp, sterile connectors, fittings, and seals. The increased market demand of biologics, the constant development of new technologies in bioprocessing, the increasing biopharmaceutical research and development, as well as the widespread use of single-use assemblies by multiple CMOs are expected to contribute to the industry’s growth within the specified period.
The legal constraints related to leachable and extractable waste disposal and also the sheer ubiquity of the multiple use system constitute some of the restraints that may somewhat limit the market access. The development of Covid-19 has accelerated an already fast-growing demand for disposable assemblies as the disposable assemblies’ technology used in rapid development of therapies and vaccines and enhance precision, speed. An example of a single-use bag assembly is the Aramus system that was produced by Entegris, Inc; COVID-19 vaccines require special storage conditions given that the vaccines require low temperatures. Largely, the patented disposable bags had low leachable and extractable and a great variety in operating-temperature which made them suitable for cold chain storage and collection.
The high incidence of cancer and infectious diseases is used to rise the demand for novel biologics for diagnosis of cancer and also, potential treatment. They include climate change, changing land-use patterns and rapid urbanization which increases the rate of infection diseases like the lower respiratory infections and HIV which have recently increased thus helping the industry to grow. For instance, based on the WHO classification, lower respiratory tract infections occupied the four ranked causes of deaths internationally. In fact, by June 2014 as pointed out by UNAIDS, there were estimated to about 38 million. charged 4 million cases of HIV infection across the globe in the year 2020.
People can get easily infected with these diseases, so proper diagnosis, treatment, including the use of patent-protected biologics, will drive the industry’s progress. In addition, new innovations in vaccines on different communicable diseases are believed to boost the industry. For example, in January this year, Moderna began a new phase of the clinical trial for a HIV vaccine that uses the mRNA technology applied in its vaccine against Covid-19. This vaccine is meant to produce antibodies that may effectively neutralise HIV particles and the above attempts depict the application of emerging technologies in the biologics segment.
The same is true for new viral diseases, which have threats of future pandemics and consequently, rationally call for collective endeavors in the development of new substitutes for vaccines. For example, in August 2022, Lytic Solutions, which provided multiple molecular biology products for research purpose, entered into a collaboration with NightHawk Biosciences in order to advance NightHawk’s vaccine plan in a new subunit monkeypox vaccine. Thus, the published technological advancements and cooperation with the related industries can potentially help to promote the implementation of SU assemblies for manufacturing new types of vaccines in the close future.
The report will cover the qualitative and quantitative data on the global Single-Use Assemblies Market. The qualitative data includes latest trends, Market players analysis, Market drivers, Market opportunity, and many others. Also, the report quantitative data includes Market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 19.1% from 2024 to 2032 |
Segmentation | By Resin Type, By Technology, By Application, By Region |
Unit | USD Billion |
By Product |
|
By Solution |
|
By Application |
|
By End User |
|
By Region |
|
The Market scope is segmented because of by Product, by Solution, by Application, By End User.
Based on the Product of the Market is segmented into Bag, Filtration, Bottle, Mixing Assemblies.
Filtration assemblies held the highest market share of around 31.25% in 2023. The enhancement in the number of regulations to be fulfilled and the requirement to reduce the chances of contamination have led to the adoption of filtration assemblies in cases of both bulk as well as final fill. Single pass filtration assemblies are easily separable and can be applied instead of stainless-steel systems eliminating sterilization steps and corresponding validation procedures. Among the type of bag assemblies, this segment is expected to grow at the highest CAGR of 20%. 02% from 2024 to 2030 for ‘Other’. Single bag assemblies in the biopharmaceutical industry are of different types and sizes as well as shapes and the multiple uses of single-use bag assemblies are cell cultivation formulation, sampling bag, situated in a buffer food-process medium, feed-process among the others.
Based on the Solution of the Market is segmented into Standard, Customized.
The Customized segment dominated the industry in 2023 and accounted for a revenue share of 75.32%. SUTs result in not only cost and time, but also 90 % of integrity testing, sterile connections, and tubing. It eliminates process time since the filtration systems are ready to use as compared to other filtration systems. The increase in market demand for biopharmaceuticals will necessitate, several production plants hence high returns. The use of single-use systems is increasing in the production of biopharmaceuticals and other products to allow fast product change-overs and manufacturing/production of distinct products in different areas throughout the same building/structure.
By Application
Based on the Application of the Market is segmented into Filtration, Cell Culture, Storage, Sampling, Fill-finish.
The filtration segment dominated the industry in 2023 and accounted for a revenue share of 29.81%. Thus, using the systems, one can easily purchase the related products for pharmaceutical manufacturers, laboratories and other end consumers, combined with facilitating the production, minimizing the time spent on sterility and cleanliness of equipment. Most players provide individualized products based on the unique characteristics of the consumers. Single-use assemblies produced by MilliporeSigma company under the brand name Mobius are fully customizable and ready to use that enables preparedness of quick launch of the manufacturing and development processes in the pharmaceutical industries.
Based on the End Use of the Market is segmented into Biopharmaceutical & pharmaceutical companies, CROS & CMOS.
Biopharmaceutical & pharmaceutical companies dominated the industry in 2023 and accounted for the highest share of 46.52%. Prospects in the advancement of the existing bio-manufacturing capacity for biopharmaceuticals explain instances that propel the application of single-use assemblies. For example, Alexion in June 2022 allocated USD 70 million in new drug production warehousing, and equipment to improve Alexion’s manufacturing, specific to Ireland. As it will be viewed further the expansion has for a goal the optimization of the biologics drug substance offer. Likewise, in May 2022 Upperton Pharma Solutions provided a plan of USD 16 million to enhance the facility Ramification might benefit the growth of the research and development area and GMP manufacturing area by ten folds.
By region, Insights into the Market in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. North America dominated the market with a share of 38.22% in 2023. The contribution of the major share could be due to the developing industries such as the biotechnology and pharmaceutical industries, developing products, and due to the elevated prevalence rate of diseases like cancer besides investment and funding of drug discovery research. For instance, in August 2022 Thermo Fisher Scientific Inc. was officiated to the single-use technology manufacturing site in Greater Nashville. The 400,000 sq ft USD 105m new facilities enable the company to accommodate the rising demand for the bioprocessing materials needed to develop new therapies as well as cancer and other diseases’ vaccines.
This site is within the framework of the company’s USD 650 million long-term investment in the expansion of bioprocessing production capacity. The Asia Pacific is expected to have the highest growth rate from 2024 to 2030 due to plans executed by top stakeholders in the market. In the past year, major investments were made to expand operations in China and Beijing in particular because new cleanrooms were established for the creation of bags and single-use filters. Cytiva disclosed in September 2021 on forming a disposable manufacturing hub in South Korea which require an investment of up to USD 52m. 5 million. This expansion is being intended to provide single-use bags to the bioprocessing industry that deals with COVID-19 vaccines.
The objective of the report is to present comprehensive analysis of Global Single-Use Assemblies Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
05 Jul 2024